The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.
Open accessAbstract
Glucocorticoids are efficient antiinflammatory agents, and their effects include transcriptional repression of several cytokines and adhesion molecules. Whereas glucocorticoids down-regulate the expression of genes relevant during inflammation, nuclear factor (NF)-kappa B/Rel proteins function as important positive regulators of these genes. The expression of intercellular adhesion molecule-1 (ICAM-1), which plays an essential role in recruitment and migration of leukocytes to sites of inflammation, is also down-regulated by glucocorticoids. We found that a functional NF-kappa B site in the ICAM-1 promoter, which can be activated by either 12-O-tetradecanoylphorbol-13-acetate or tumor necrosis factor-alpha (TNF alpha), is also the target for glucocorticoids. In this report we present evidence that the ligand-activated glucocorticoid receptor (GR) is able to repress RelA-mediated activation of the ICAM-1 NF-kappa B site. Conversely, transcriptional activation by GR via a glucocorticoid response element is specifically repressed by RelA, but not by other NF-kappa B/Rel family members. Mutational analysis of GR demonstrates that the DNA binding domain and the ligand binding domain are required for the functional repression of NF-kappa B activation. Despite the importance of the DNA binding domain, we found that the transcriptional repression of NF-kappa B, mediated by GR, is not caused by binding of GR to the ICAM-1 NF-kappa B element, but by a physical interaction between the GR and RelA protein. The repressive effect of GR on NF-kappa B-mediated activation was not shared by other steroid/thyroid receptors. Only the progesterone receptor, which belongs to the same subfamily as GR and which possesses high homology with GR, was able to repress NF-kappa B-mediated transcription. These studies highlight a possible molecular mechanism that can explain the antiinflammatory effects of glucocorticoid treatment during inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
A human retinoic acid receptor which belongs to the family of nuclear receptors
Petkovich, M., Brand, N. J., Krust, A., & Chambon, P. (1987) · Nature · doi:10.1038/330444a0 · Cited by 2,214
IκB: a Specific Inhibitor of the NF-κB Transcription Factor
Baeuerle, P. A., & Baltimore, D. (1988) · Science · doi:10.1126/science.3140380 · Cited by 2,155
Diamond, M. I., Miner, J. N., Yoshinaga, S. K., & Yamamoto, K. R. (1990) · Science · doi:10.1126/science.2119054 · Cited by 1,292
Ray, A., & Prefontaine, K. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.752 · Cited by 1,064
Determinants of target gene specificity for steroid/thyroid hormone receptors
Umesono, K., & Evans, R. M. (1989) · Cell · doi:10.1016/0092-8674(89)90051-2 · Cited by 948
Functional domains of the human glucocorticoid receptor
Giguère, V., Hollenberg, S. M., Rosenfeld, M. G., & Evans, R. M. (1986) · Cell · doi:10.1016/0092-8674(86)90339-9 · Cited by 918
The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B.
Schmitz, M. L., & Baeuerle, P. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04950.x · Cited by 796
Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates
Boumpas, D. T., Chrousos, G. P., Wilder, R. L., Cupps, T. R., & Balow, J. E. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-12-199312150-00007 · Cited by 778
Steroid Hormone Receptors: Interaction with Deoxyribonucleic Acid and Transcription Factors*
TRUSS, M., & BEATO, M. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-4-459 · Cited by 741
Cited by
Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541
Sapolsky, R. M. (2000) · Endocrine Reviews · doi:10.1210/er.21.1.55 · Cited by 7,533
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,617
The Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
Steroid hormone receptors: Many Actors in search of a plot
Beato, M., Herrlich, P., & Schütz, G. (1995) · Cell · doi:10.1016/0092-8674(95)90201-5 · Cited by 1,823
Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., & Baldwin, A. S. (1995) · Science · doi:10.1126/science.270.5234.283 · Cited by 1,699
DNA binding of the glucocorticoid receptor is not essential for survival
Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81183-6 · Cited by 1,068
Neuroendocrine Regulation of Immunity
Webster, J. I., Tonelli, L., & Sternberg, E. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.082401.104914 · Cited by 957
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
“unique transactivation functions of p65 (227).”
BackgroundMolecular Determinants of Glucocorticoid Receptor Function and Tissue Sensitivity to Glucocorticoids
BAMBERGER, C. M., SCHULTE, H. M., & CHROUSOS, G. P. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-3-245 · Cited by 889
Antidepressants and Hypothalamic-Pituitary-Adrenocortical Regulation
HOLSBOER, F., & BARDEN, N. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-2-187 · Cited by 852
Intercellular adhesion molecule-1
van de Stolpe, A., & van der Saag, P. T. (1996) · Journal of Molecular Medicine · doi:10.1007/bf00202069 · Cited by 802
Self-citationMcKay, L. I., & Cidlowski, J. A. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0375 · Cited by 805
“The fact that mutual functional antagonism between GR and NF-kB requires multiple domains of both proteins (1, 4, 146, 149), while physical interaction requires only a subset of those domains (the GR DNA-binding region and the p65 Rel region), argues against a simple mechanism of antagonism in which direct physical co…”
BackgroundGlucocorticoids in T Cell Development and Function
Ashwell, J. D., Lu, F. W. M., & Vacchio, M. S. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.309 · Cited by 782
The Aryl Hydrocarbon Receptor Complex and the Control of Gene Expression
Beischlag, T. V., Morales, J. L., Hollingshead, B. D., & Perdew, G. H. (2008) · Critical Reviews™ in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v18.i3.20 · Cited by 727
Repression of the Interleukin-6 Promoter by Estrogen Receptor Is Mediated by NF-κB and C/EBPβ
Stein, B., & Yang, M. X. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.9.4971 · Cited by 704
Molecular determinants of crosstalk between nuclear receptors and toll-like receptors
Ogawa, S., Lozach, J., Benner, C., Pascual, G., Tangirala, R. K., Westin, S., Hoffmann, A., Subramaniam, S., David, M., Rosenfeld, M. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.029 · Cited by 647
NF-κB: At the Borders of Autoimmunity and Inflammation
Barnabei, L., Laplantine, E., Mbongo, W., Rieux-Laucat, F., & Weil, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.716469 · Cited by 630
Regulation of intercellular adhesion molecule-1 (CD54) gene expression
Roebuck, K. A., & Finnegan, A. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.6.876 · Cited by 560
Nissen, R. M., & Yamamoto, K. R. (2000) · Genes & Development · doi:10.1101/gad.827900 · Cited by 559
Webster, J. C., Oakley, R. H., Jewell, C. M., & Cidlowski, J. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121455098 · Cited by 482
Mallard, B. A., Dekkers, J. C., Ireland, M. J., Leslie, K. E., Sharif, S., Lacey Vankampen, C., Wagter, L., & Wilkie, B. N. (1998) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(98)75612-7 · Cited by 459
The Dominant Negative Activity of the Human Glucocorticoid Receptor β Isoform
Oakley, R. H., Jewell, C. M., Yudt, M. R., Bofetiado, D. M., & Cidlowski, J. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27857 · Cited by 453
Tumor necrosis factor-α: molecular and cellular mechanisms in skeletal pathology
Nanes, M. S. (2003) · Gene · doi:10.1016/s0378-1119(03)00841-2 · Cited by 440
NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells
Bentires-Alj, M., Barbu, V., Fillet, M., Chariot, A., Relic, B., Jacobs, N., Gielen, J., Merville, M.-P., & Bours, V. (2003) · Oncogene · doi:10.1038/sj.onc.1206056 · Cited by 430
Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor
Reichardt, H. M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.7168 · Cited by 429
Lu, N. Z., Wardell, S. E., Burnstein, K. L., Defranco, D., Fuller, P. J., Giguere, V., Hochberg, R. B., McKay, L., Renoir, J.-M., Weigel, N. L., et al. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.9 · Cited by 426
Molecular mechanisms of glucocorticoid action and resistance
Schaaf, M. J. M., & Cidlowski, J. A. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00263-7 · Cited by 416
Update on glucocorticoid action and resistance
Nelson, H. S., Leung, D. Y. M., & Bloom, J. W. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.97 · Cited by 413
Ah Receptor and NF-κB Interactions, a Potential Mechanism for Dioxin Toxicity
Tian, Y., Ke, S., Denison, M. S., Rabson, A. B., & Gallo, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.510 · Cited by 405
Interaction of Steroid Hormone Receptors with the Transcription Initiation Complex
BEATO, M., & SÁNCHEZ-PACHECO, A. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-6-587 · Cited by 405
McKay, L. I., & Cidlowski, J. A. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.1.0044 · Cited by 405
Transcriptional cross-talk, the second mode of steroid hormone receptor action
Göttlicher, M., Heck, S., & Herrlich, P. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050242 · Cited by 388
Nuclear Factor Kappa B: Important Transcription Factor and Therapeutic Target
Lee, J., & Burckart, G. J. (1998) · The Journal of Clinical Pharmacology · doi:10.1177/009127009803801101 · Cited by 365
Neural-immune interactions in health and disease.
Sternberg, E. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119807 · Cited by 363
De Bosscher, K., Schmitz, M. L., Vanden Berghe, W., Plaisance, S., Fiers, W., & Haegeman, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13504 · Cited by 363
Schmidt, S., Rainer, J., Ploner, C., Presul, E., Riml, S., & Kofler, R. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401456 · Cited by 360
Wright, M. C., Issa, R., Smart, D. E., Trim, N., Murray, G. I., Primrose, J. N., Arthur, M. J. P., Iredale, J. P., & Mann, D. A. (2001) · Gastroenterology · doi:10.1053/gast.2001.27188 · Cited by 356
Negative Interaction between the RelA(p65) Subunit of NF-κB and the Progesterone Receptor
Kalkhoven, E., Wissink, S., van der Saag, P. T., & Burg, B. V. D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.6217 · Cited by 352
Self-citationNewton, R., & Holden, N. S. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038794 · Cited by 328
Transcription factors and asthma
Barnes, P., & Adcock, I. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.12010221 · Cited by 320
Ayroldi, E., Migliorati, G., Bruscoli, S., Marchetti, C., Zollo, O., Cannarile, L., D'Adamio, F., & Riccardi, C. (2001) · Blood · doi:10.1182/blood.v98.3.743 · Cited by 320
Vayssière, B. M., Dupont, S., Choquart, A., Petit, F., Garcia, T., Marchandeau, C., Gronemeyer, H., & Resche-Rigon, M. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.9.9979 · Cited by 311
Mechanisms of glucocorticoid signalling
Schoneveld, O. J. L. M., Gaemers, I. C., & Lamers, W. H. (2004) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2004.09.004 · Cited by 310
Molecular mechanisms of anti‐inflammatory action of glucocorticoids
Cato, A. C. B., & Wade, E. (1996) · BioEssays · doi:10.1002/bies.950180507 · Cited by 309
Sheppard, K.-A., Phelps, K. M., Williams, A. J., Thanos, D., Glass, C. K., Rosenfeld, M. G., Gerritsen, M. E., & Collins, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29291 · Cited by 305
Retinoic Acid Blocks Adipogenesis by Inhibiting C/EBPβ-Mediated Transcription
Schwarz, E. J., Reginato, M. J., Shao, D., Krakow, S. L., & Lazar, M. A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1552 · Cited by 302
Beck, I. M. E., Vanden Berghe, W., Vermeulen, L., Yamamoto, K. R., Haegeman, G., & De Bosscher, K. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0013 · Cited by 298
Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF- B site
Galien, R., & Garcia, T. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.12.2424 · Cited by 298
Ikappa Balpha -independent downregulation of NF-kappa B activity by glucocorticoid receptor
Heck, S. (1997) · The EMBO Journal · doi:10.1093/emboj/16.15.4698 · Cited by 295
Luo, Y., & Zheng, S. G. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00604 · Cited by 288
Crosstalk between the glucocorticoid receptor and other transcription factors: Molecular aspects
Kassel, O., & Herrlich, P. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.07.003 · Cited by 277
A model of transcriptional regulatory networks based on biases in the observed regulation rules
Harris, S. E., Sawhill, B. K., Wuensche, A., & Kauffman, S. (2002) · Complexity · doi:10.1002/cplx.10022 · Cited by 277
Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma
Wordinger, R. J., & Clark, A. F. (1999) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(98)00035-4 · Cited by 260
A fully dissociated compound of plant origin for inflammatory gene repression
De Bosscher, K., Berghe, W. V., Beck, I. M. E., Van Molle, W., Hennuyer, N., Hapgood, J., Libert, C., Staels, B., Louw, A., & Haegeman, G. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505554102 · Cited by 260
Transcriptional regulation by steroid hormones
Beato, M., Chávez, S., & Truss, M. (1996) · Steroids · doi:10.1016/0039-128x(96)00030-x · Cited by 259
Ray, P., Ghosh, S. K., Zhang, D.-H., & Ray, A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00487-0 · Cited by 256
Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids
Almawi, W., & Melemedjian, O. (2002) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0280069 · Cited by 242
Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor
Clark, A. R., & Belvisi, M. G. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.12.004 · Cited by 209
“…bind to and activate expression via canonical GC response elements, but did not substantially impair the repression of AP-1 or NF-κB-dependent reporters by GR (Heck et al., 1994; Mukaida et al., 1994; Caldenhoven et al., 1995; Heck et al., 1997; Liden et al., 1997; Reichardt et al., 2001).”
InfluentialEndothelial glucocorticoid receptor is required for protection against sepsis
Goodwin, J. E., Feng, Y., Velazquez, H., & Sessa, W. C. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210200110 · Cited by 142
Dynamic regulation of glucocorticoid signalling in health and disease
Biddie, S. C., Conway-Campbell, B. L., & Lightman, S. L. (2012) · Rheumatology · doi:10.1093/rheumatology/ker215 · Cited by 143
Discovery of Glucocorticoid Receptor-β in Mice with a Role in Metabolism
Hinds, T. D., Ramakrishnan, S., Cash, H. A., Stechschulte, L. A., Heinrich, G., Najjar, S. M., & Sanchez, E. R. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0411 · Cited by 129
A potential role of activated NF-κB in the pathogenesis of euthyroid sick syndrome
Nagaya, T., Fujieda, M., Otsuka, G., Yang, J.-P., Okamoto, T., & Seo, H. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7771 · Cited by 107
Glucocorticoid receptor represses proinflammatory genes at distinct steps of the transcription cycle
Gupte, R., Muse, G. W., Chinenov, Y., Adelman, K., & Rogatsky, I. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309898110 · Cited by 70
Woo, H.-H., Orbach, M. J., Hirsch, A. M., & Hawes, M. C. (1999) · The Plant Cell · doi:10.1105/tpc.11.12.2303 · Cited by 69
Altered glucocorticoid receptor signaling cascade in lymphocytes of bipolar disorder patients
Spiliotaki, M., Salpeas, V., Malitas, P., Alevizos, V., & Moutsatsou, P. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2006.02.006 · Cited by 58
Gross, K. L., Oakley, R. H., Scoltock, A. B., Jewell, C. M., & Cidlowski, J. A. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0051 · Cited by 56
Bladh, L.-G., Lidén, J., Dahlman-Wright, K., Reimers, M., Nilsson, S., & Okret, S. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.005801 · Cited by 49
Determinants of the heightened activity of glucocorticoid receptor translational isoforms
Bender, I. K., Cao, Y., & Lu, N. Z. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1009 · Cited by 19
Metadata
- Authors
- Caldenhoven, E., Liden, J., Wissink, S., Van de Stolpe, A., Raaijmakers, J., Koenderman, L., Okret, S., Gustafsson, J. A., & Van der Saag, P. T.
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1995-04
- Volume
- 9
- Issue
- 4
- Pages
- 401-412
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- OpenAlex
- W2100250344
- Cited by
- 489
- References
- 56
- FWCI
- 15.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.